# Clinical and Translational Science Center

> **NIH NIH UL1** · WEILL MEDICAL COLL OF CORNELL UNIV · 2021 · $7,691,055

## Abstract

A. ADMINISTRATIVE CORE
PROJECT SUMMARY/ABSTRACT
During the past ten years the Weill Cornell Clinical and Translational Science Center (CTSC) has established
an inclusive, strong and highly effective governance structure incorporating our partners as active members. As
lead institution, Weill Cornell Medicine (WCM) serves as an academic home through which essential resources,
technological tools and education programs can be efficiently shared and managed. The partner institutions
comprising the CTSC are also neighbors located on York Avenue “The Translational Research Avenue”. Within
the immediate area are: Memorial Sloan Kettering Cancer Center (MSK); Hospital for Special Surgery (HSS);
Hunter College (HC), School of Nursing (HCSON) and its Center for Translational and Basic Research
(CTBR)/Research Center for Minority Institutions (RCMI), School of Urban Public Health; and the Animal Medical
Center. In addition to this partnership, the CTSC has extensive ties to both Cornell University, Ithaca (CU)
(particularly with the Nanobiotechnology Center, the Schools of Bioengineering and Veterinary Medicine), The
McGovern Center for Venture Development and to the Burke Medical Research Institute for Rehabilitation, White
Plains NY. The resulting cluster of institutions forms a unique and cohesive biomedical complex fulfilling the
NCATS roadmap initiative of breaking-down institutional and disciplinary silos to accelerate translational
research. Individually, the partner institutions are superb centers of intellectual and academic excellence. Their
integration into the CTSC harnesses their distinctive characteristics, hastening clinical and translational research
breakthroughs for improved patient care. The CTSC Administrative Core is tightly integrated with Evaluation
and Continuous Improvement and Quality and Efficiency. Administration oversees the management of the
CTSC, including introduction of the Balanced Scorecard approach. Evaluation and Tracking accomplishes the
assessment of translational research and training innovations, introducing in this cycle the integration of the
Results Based Accountability framework central to CTSA Common metrics, and the idea of targeted micro-
experiments that can lead to multi-hub pilot studies and eventual impact on the CTSA network and the field. The
Quality and Efficiency section enhances trial efficiency and recruitment through the introduction of a CTSC
Performance Management Team. The Performance Management Team (PMT) will be the mechanism by which
the CTSC improves research process performance. It will incorporate both the Balanced Scorecard approach
used by the AC and the Results-Based Accountability approach that is the foundation of the CTSA Common
Metrics effort.

## Key facts

- **NIH application ID:** 10213868
- **Project number:** 5UL1TR002384-05
- **Recipient organization:** WEILL MEDICAL COLL OF CORNELL UNIV
- **Principal Investigator:** JULIANNE L IMPERATO-MCGINLEY
- **Activity code:** UL1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $7,691,055
- **Award type:** 5
- **Project period:** 2017-09-05 → 2022-07-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10213868

## Citation

> US National Institutes of Health, RePORTER application 10213868, Clinical and Translational Science Center (5UL1TR002384-05). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10213868. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*